Actively Recruiting
Study of MediDrink Platinum Protein Blend Alone or with PeptiStrong to Improve Fitness and Muscle Strength in Adults 60 and Older with Sarcopenia
Led by Nuritas Ltd · Updated on 2026-01-07
75
Participants Needed
2
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effects of MediDrink Platinum containing a novel protein blend SPR-01, alone and combined with PeptiStrong, on general fitness in malnourished adults aged 60 and above with sarcopenia. The study is multicenter, randomized, and actively controlled, focusing on how these nutritional supplements impact fitness levels and physical function in this elderly population. Participants will first receive the base formula MediDrink Platinum for two weeks. After this, they will be randomly assigned to one of two groups for ten weeks one group receives the base formula with SPR-01 alone at least 1200 kcalday, and the other receives the base formula with SPR-01 plus 2.4gday of PeptiStrong, a fava bean protein hydrolysate. Both groups doses are tailored to individual nutritional needs. Throughout the study, participants will undergo assessments including general well-being measured by the Barthel index, hand grip strength via dynamometer, fat-free body mass using bioelectrical impedance analysis, and physical performance through the time up & go test. These measures occur during the initial two weeks on the base formula and continue during the subsequent ten weeks of assigned supplementation. The study includes monitoring of clinical responses and self-assessed health status, lasting a total of 12 weeks.
CONDITIONS
Brief Title
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Research Team
E
Edit Nadasi, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here